News

Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again

Yahoo

Wall Street put the AI trade on a diet six weeks ago. The maker of Zepbound has been doing the bulking up. Since its Oct. 6 record, Nvidia (NVDA) has shed more than $1.7 trillion in market value. Eli Lilly (LLY) has added more than $250 billion over the same stretch, a gain topped only by Apple (AAPL) among the market's biggest stocks. That's a 25% gain for the maker of Zepbound and Mounjaro against a 32% drop for the AI chip king through Friday's close. The gap kept widening Monday, a day before Nvidia's first earnings report since Jensen Huang's exit. And it's not just one matchup.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.